Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clonal Architecture of ASXL1-mutated Myelofibrosis
NCT05710211Recruiting
- Sponsor
- Centre Hospitalier Universitaire d'Angers
- Start
- Apr 2023
- Primary completion
- Apr 2027
- Countries
- 1
01
Overview
Single-arm trial, sponsored by Centre Hospitalier Universitaire d'Angers. Primary endpoint: Identify subgroups of ASXL1-mutated myelofibrosis based on clonal architecture data at 24 months. Started Apr 2023; status: recruiting.
Beyond the preview
Go deeper on NCT05710211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05710211.